François Clément Bidard, Erica L. Mayer, Yeon Hee Park, Wolfgang Janni, Cynthia X. Ma, Massimo Cristofanilli, Giampaolo Bianchini, Kevin Kalinsky, Hiroji Iwata, Stephen K.L. Chia, Adam Brufsky, Peter A. Fasching, Zbigniew Nowecki, Javier Pascual, Nuri Karadurmus, Einav Nili Gal-Yam, Arkendu Chatterjee, Manuel Selvi Miralles, Cynthia Huang Bartlett, Nicholas Turner. "First-line (1L) camizestrant (CAMI) for emergent
                    <i>ESR1</i>
                    mutations (
                    <i>ESR1</i>
                    m) in advanced breast cancer (ABC): Final progression-free survival 2 (PFS2) from the phase III SERENA-6 trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.17_suppl.lba1007